Verkuil, Arie Hans

Lade...
Profilbild
E-Mail-Adresse
Geburtsdatum
Projekt
Organisationseinheiten
Berufsbeschreibung
Nachname
Verkuil
Vorname
Arie Hans
Name
Verkuil, Arie Hans

Suchergebnisse

Gerade angezeigt 1 - 10 von 40
Vorschaubild nicht verfügbar
Publikation

SMEs talk - startups walk - How startups can benefit from the use of a digital maturity model for SMEs as part of digital transformation

2024, Klotz, Patrick, Eisenbart, Barbara, Verkuil, Arie Hans

While digital transformation has been widely implemented in large corporations, there is a big potential for startups and SMEs which are lacking behind in utilizing this opportunity. This paper aims to raise awareness among startups and SMEs about digital transformation by developing a digital maturity model adopted especially for international distributed work. The model serves as a framework for startups and SMEs to understand which dimensions influence and are important for digital transformation, and what specific questions are relevant for each of the dimensions.

Vorschaubild nicht verfügbar
Publikation

Religiöse Wurzeln des Achtsamkeitskonzepts als Bezugspunkt für ethische Führung

2021, Verkuil, Arie Hans, Schulte, Volker, Steinebach, Christoph, Veth, Klaske

Der Artikel reflektiert die buddhistische, hinduistische und christliche Tradition des Achtsamkeitskonzepts als Bezugspunkt für ethische Führung.

Vorschaubild nicht verfügbar
Publikation

Case WAWTA (app for the blind)

2021, Raksasakul, Punchaya, Milow, Uta, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans

Vorschaubild nicht verfügbar
Publikation

Case Study "Perseo Pharma"

2020, Kabous, Laila, Verkuil, Arie Hans, Meyer, Rolf, Aeschbacher, Marc

Founded in 2019, Perseo Pharma is a preclinical-stage biotech company with a unique asset for the development of enzyme therapies. Perseo Pharma possesses an innovative and proprietary enzyme shielding technology. Founded as independent spin-off of INOFEA AG, the company focuses on therapeutic enzymes for the treatment of cancer and rare genetic diseases. Over the past three decades, 30 therapeutic enzymes have been approved by EMA and FDA generating yearly 40bn. Therapeutic enzymes address a wide variety of indications, ranging from rare genetic diseases (enzyme replacement therapies) to oncology (key tumor-element depletion therapies). This offers biotech companies different opportunities and application fields for further development of enzyme therapeutics. The goal of this research is to analyze the case based on the 7-key model and provide recommendations on the financing opportunities available for Perseo pharma.

Vorschaubild nicht verfügbar
Publikation

Religious roots of the concept of mindfulness as a reference point for ethical leadership

2022, Verkuil, Arie Hans, Schulte, Volker, Steinebach, Christoph, Veth, Klaske

Vorschaubild nicht verfügbar
Publikation

Case Roodee LMS

2021, Kunsapsak, Chutikarn, Milow, Uta, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans

Case Study, innovative learning management platform, Malaysia

Vorschaubild nicht verfügbar
Publikation

Case Jinn-Bot Robotics Design GmbH

2021, Reineke, Rolf-Dieter, Seeberger, Roger, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans

Vorschaubild nicht verfügbar
Publikation

Case biogas and solar service provider

2021, Syed, Obed Rashdi, Milow, Uta, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans

Vorschaubild nicht verfügbar
Publikation

Case Brextor

2021, Reineke, Rolf-Dieter, Portmann, Alois, Reber, Marcel, Milow, Uta, Reineke, Rolf-Dieter, Verkuil, Arie Hans

Vorschaubild nicht verfügbar
Publikation

Case study essento

2020, Meyer, Rolf, Verkuil, Arie Hans, Aeschbacher, Marc